Key result
Combined ablation and antiarrhythmic drug therapy maintained sinus rhythm in 88.9% of patients who converted from atrial fibrillation to typical atrial flutter.
Why the study?
Does combined ablation and antiarrhythmic drug therapy improve maintenance of sinus rhythm in patients with atrial fibrillation who converted to atrial flutter on antiarrhythmic drugs?
Observational (n=13)
Does combined ablation and antiarrhythmic drug therapy improve maintenance of sinus rhythm in patients with atrial fibrillation who converted to atrial flutter on antiarrhythmic drugs?
Combined ablation and antiarrhythmic therapy is an effective strategy for maintaining sinus rhythm in patients whose atrial fibrillation converts to atrial flutter on medication.
Answers are grounded in this paper and cite their sources.
May support combined ablation plus antiarrhythmic drugs after AF-to-AFL conversion; leaves open need for randomized confirmation.
INTRODUCTION: Maintenance of sinus rhythm in patients with recurrent atrial fibrillation is often difficult to achieve with pharmacologic therapy. Complex catheter ablative procedures are being developed, but efficacy and safety issues remain to be clarified. We hypothesized that combined pharmacologic and simple ablative therapies in a targeted subset of patients will improve success in the treatment of atrial fibrillation. METHODS AND RESULTS: We identified 13 patients (mean age 61.5 +/- 16.2 years) with atrial fibrillation who converted to electrocardiographic atrial flutter during antiarrhythmic drug treatment. Surface ECG suggested "typical" atrial flutter in 11 patients and "atypical" atrial flutter in 2. Intracardiac mapping and entrainment studies revealed 9 patients had counterclockwise isthmus-dependent atrial flutter, and the remaining 4 had complex activation patterns, suggesting the presence of multiple wavefronts. All 9 patients with typical atrial flutter underwent successful ablation. None of the 4 patients with complex activation patterns had successful ablation. Patients were followed for recurrences of atrial arrhythmias via clinic visits, record review, and interviews. In patients who underwent successful ablation and continued on antiarrhythmic drugs, 88.9% remain in sinus rhythm after a mean follow-up of 14.3 +/- 6.9 months (range 1 to 28). CONCLUSION: In patients who experience conversion of atrial fibrillation to atrial flutter during antiarrhythmic drug treatment, ablation and continuation of pharmacologic therapy is a safe and effective means of achieving and maintaining sinus rhythm.
No takes yet. Share an insight, caveat, or question.
Huang et al. (1998) conducted an observational in Atrial fibrillation (n=13). Ablation and continuation of antiarrhythmic drugs was evaluated on Maintenance of sinus rhythm. Combined ablation and antiarrhythmic drug therapy maintained sinus rhythm in 88.9% of patients who converted from atrial fibrillation to typical atrial flutter.
Synapse has enriched 10 related papers. Consider them for comparative context: